Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease

Overview of attention for article published in Frontiers in Genetics, April 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,211 followers.

🧬Pegunigalsidasa alfa: una nueva enzima alfa-galactosidasa recombinante pegilada para el tratamiento de la enfermedad de Fabry: https://t.co/fFHxk43min

22 May 2024

Reply Repost Favourite

https://t.co/qBZiaakxcW

13 Apr 2024

Reply Repost Favourite

Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease https://t.co/krXCjUmrwR #FrontGenet

12 Apr 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.